Indeed, SSA ameliorates AD-like skin inflammation by reducing EGR1-mediated TSLP expression in HaCaT keratinocytes [13]; however, the effect of SSA on the expression of FLG remains unclear. This evidence concerns the gene FLG and Alzheimer disease.